APA (7th ed.) Citation

Colevas, A. D., Bahleda, R., Braiteh, F., Balmanoukian, A., Brana, I., Chau, N. G., . . . Powderly, J. (2018). Safety and clinical activity of atezolizumab in head and neck cancer: Results from a phase I trial. Annals of Oncology, 29(11), 2247. https://doi.org/10.1093/annonc/mdy411

Chicago Style (17th ed.) Citation

Colevas, A D., et al. "Safety and Clinical Activity of Atezolizumab in Head and Neck Cancer: Results from a Phase I Trial." Annals of Oncology 29, no. 11 (2018): 2247. https://doi.org/10.1093/annonc/mdy411.

MLA (9th ed.) Citation

Colevas, A D., et al. "Safety and Clinical Activity of Atezolizumab in Head and Neck Cancer: Results from a Phase I Trial." Annals of Oncology, vol. 29, no. 11, 2018, p. 2247, https://doi.org/10.1093/annonc/mdy411.